Psychiatry News

NEW YORK — Time, financial and energy constraints are the leading barriers to mental health care access for health care workers, according to research presented at the American Psychiatric Association annual meeting.

The number of pills containing illicit fentanyl that were seized by United States law enforcement in 2023 was 2,300 times greater than the number in 2017, according to a study published in the International Journal of Drug Policy.

Newron Pharmaceuticals announced positive topline results from its phase 2/3 study of evenamide for patients with chronic schizophrenia who have an inadequate response to current treatment with a second-generation antipsychotic.

Life as a health care professional can be stressful, but there is a quick technique that can combat feelings of tension.

Less than 15% of surveyed U.S. college students knew how to use naloxone in the event of an overdose, according to results published in JAMA Pediatrics.

Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.

NEW YORK — Vaccination for SARS-CoV-2 before and during pregnancy was not significantly associated with symptoms of postpartum depression, according to research presented at the American Psychiatric Association annual meeting.

DENVER — For those diagnosed with migraine, gastrointestinal issues or both, psychiatric comorbidities increase the risk of worsened physical and mental states, according to an expert at the American Academy of Neurology annual meeting.

A physician practice owner’s week is spent seeing and caring for patients and managing the day-to-day issues of the practice.

The FDA’s approval of Leqembi in July 2023 triggered a wave of discussion in the medical community on how to prescribe and properly administer the amyloid-targeting antibody to treat those diagnosed with Alzheimer’s disease.